CHE
CHEMED CORPPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 1 to May 8 ▼ 2 days of insider sells: $867.8K by 2 insiders, avg $421.27
- Jun 9 ▼ 1 insider sell $602.6K at $447.33
- Jul 31 to Aug 3 ▼ 2 days of insider sells: $1.2M by 2 insiders, avg $538.86
- Aug 14 ▼ Short interest jumps 38.4% to 638.4K
- Aug 21 ▼ 2 insiders sell $1.6M at $541.12
- Sep 18 ▼ 1 insider sell $1.0M at $501.40
- Sep 28 ▼ 1 insider sell $1.0M at $513.45
- Oct 27 ▲ Chemed reported Q3 2026 revenue of $690.9M (+10.6% YoY) and adjusted…
- Oct 28 ▲ Jefferies upgrades
- Nov 2 to Nov 3 ▼ 2 days of insider sells: $1.6M by 2 insiders, avg $537.67
- Nov 6 Dividend: Chemed Corporation Declares Quarterly Dividend of 70 Cents
- Nov 11 ▼ 1 insider sell $547.6K at $547.61
Signal stack
Where each data set points today.
- InsidersBEARISH
5 insiders sold $10.0M.
- InstitutionsMIXED
Q3 2026: 32 added (2 new), 31 trimmed or exited. Largest new: Assenagon Asset Management S.A $21.9M.
- AnalystsBULLISH
6 of 9 rate it Buy or better. Every target is above the price.
- Short sellersBUILDING
Short interest +16.0% to 796.0K shares. 5.0 days to cover, ≈6.1% of shares.
- TrendUPTREND
6% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Boston Partners | ADD | $190.4M |
| FIRST TRUST ADVISORS LP | TRIM | $74.0M |
| Qube Research & Technologies Ltd | DOUBLED | $54.8M |
| LOS ANGELES CAPITAL MANAGEMENT LLC | DOUBLED | $23.5M |
| Assenagon Asset Management S.A. | NEW | $21.9M |
| BARCLAYS PLC | DOUBLED | $19.0M |
| BANK OF NOVA SCOTIA | DOUBLED | $17.7M |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | ADD | $13.7M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
9 analystsPrice is below the lowest target. Median implies +13%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 29, 2026 | RBC Capital MAINTAIN | Sector Perform |
| Oct 29, 2026 | UBS MAINTAIN | Buy |
| Oct 29, 2026 | Oppenheimer MAINTAIN | Outperform |
| Oct 28, 2026 | Jefferies UPGRADE | Buy |
| Sep 25, 2026 | UBS INITIATE | Buy |
| Jul 31, 2026 | Oppenheimer MAINTAIN | Outperform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
| 🔒 Fresh data, subscribers only Nov 13, 2026 | GIFT | |
LEE SPENCER S executive vice president Nov 11, 2026 | SELL | $547.6K |
MCNAMARA KEVIN J president and CEO Nov 3, 2026 | SELL | $1.1M |
LEE SPENCER S executive vice president Nov 2, 2026 | SELL | $494.2K |
HUTTON THOMAS C vice president Oct 20, 2026 | AWARD | $2.0M |
MCNAMARA KEVIN J president and CEO Oct 20, 2026 | AWARD | $18.8M |
LEE SPENCER S executive vice president Oct 20, 2026 | AWARD | $3.7M |
Witzeman Michael D VP & Chief Financial Officer Oct 20, 2026 | AWARD | $6.5M |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
16 filings · 3 press releases · 4 bullish · 1 bearish · 4 mixed · 7 neutral- NEUTRAL PRESS RELEASENov 6, 2026
Chemed Corp. declared a quarterly cash dividend of $0.70 per share, unchanged from the prior…
Dividend unchanged, no signal of change in capital allocation policy. Monitor next quarterly earnings for any update on payout ratio or buyback activity.
- BEARISH CLUSTERNov 5, 2026
CEO Kevin McNamara and EVP Spencer Lee sold a combined $1.57M in open-market sales over two days…
The sales are small relative to market cap (0.023%) and follow a strong earnings beat, reducing the bearish signal. However, both the CEO and EVP sold without a 10b5-1 plan, which warrants…
- NEUTRAL 144Nov 3, 2026
Kevin J. McNamara, an officer/director of Chemed Corp, filed a Form 144 notice of intent to sell…
The insider has been selling a consistent 2,000-share block each month since August 2026, suggesting a pre-arranged 10b5-1 plan or routine portfolio diversification. No material change in company…
- MIXED INST-CLUSTEROct 27, 2026
Chemed's Q2 2026 institutional cluster shows a mixed picture: 59 funds accumulated $98.5M in net…
The divergence between strong Q3 earnings and the Q2 institutional cluster suggests the sellers may have acted on concerns that were not realized. Watch for Q3 13F filings (due by Nov 14, 2026) to…
All CHE filing & press-release reports (19)
- PRESS-RELEASE reportNov 6, 2026
- CLUSTER reportNov 5, 2026
- 144 reportNov 3, 2026
- INST-CLUSTER reportOct 27, 2026
- 8-K reportOct 27, 2026
- PRESS-RELEASE reportOct 27, 2026
- INST-CLUSTER reportOct 23, 2026
- PRESS-RELEASE reportOct 1, 2026
- PRESS-RELEASE reportSep 16, 2026
- CLUSTER reportAug 24, 2026
- CLUSTER reportAug 4, 2026
- CLUSTER reportAug 4, 2026
- PRESS-RELEASE reportJul 28, 2026
- PRESS-RELEASE reportMay 18, 2026
- CLUSTER reportMay 1, 2026
- 8-K reportApr 23, 2026
- PRESS-RELEASE reportApr 23, 2026
- 8-K reportApr 13, 2026
- 8-K reportFeb 25, 2026